Caitlyn Miller
 
			    
				Company: TwoStep Therapeutics
Job title: Co-Founder & Chief Executive Officer
Seminars:
Overcoming Tumor Heterogeneity via Multispecific Targeting 9:15 am
Scientific rationale for TwoStep Therapeutics’ multi-specific targeting agent “PIP” and how it enables broad applicability across solid tumors Overview of the PIP targeting platform, featuring modular formats with tunable PK and compatibility with diverse payloads Preclinical development of PIP-drug conjugates, their efficacy and safety, and comparison to conventional single-antigen targeting approachesRead more
															day: Day Two
							
 
				